Meloxoral

Meloxicam, the active ingredient in Meloxoral, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an unspecified dosage form for oral use. It reduces pain and inflammation associated with osteoarthritis, rheumatoid arthritis and other musculoskeletal conditions.

GNH USA supplies Meloxoral as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxoral (meloxicam) is indicated for inflammatory and painful conditions affecting the musculoskeletal system.

- Osteoarthritis: reduces joint pain and improves functional mobility. - Rheumatoid arthritis: alleviates synovial inflammation and joint swelling. - Acute pain: provides short‑term analgesic relief for post‑procedural or injury‑related pain.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal upset (nausea, dyspepsia) - Headache - Dizziness - Peripheral edema - Elevated blood pressure - Skin rash

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding - Cardiovascular events (myocardial infarction, stroke) - Hepatic enzyme elevation or hepatitis - Severe skin reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis) - Renal impairment or failure - Anaphylaxis or severe hypersensitivity

Before initiating meloxicam therapy, clinicians should consider several safety measures.

- Renal function assessment: monitor serum creatinine, especially in elderly or dehydrated patients. - Cardiovascular risk evaluation: use cautiously in patients with established heart disease or hypertension. - Gastro‑intestinal history review: avoid in individuals with active peptic ulcer disease or recent GI bleeding. - Concomitant NSAID avoidance: do not combine with other NSAIDs or aspirin without medical supervision. - Lowest effective dose: prescribe the minimal dose needed for symptom control and limit treatment duration. - Store at room temperature: keep in the original container, protect from moisture and light.

Meloxoral can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Lithium: elevated lithium serum concentrations leading to toxicity. - Methotrexate: enhanced methotrexate toxicity, especially renal impairment. - ACE inhibitors or diuretics: possible reduction in renal function. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency.

Moderate Interactions (Monitor Closely): - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Corticosteroids: increased risk of ulceration and bleeding. - Diuretics: potential for reduced antihypertensive effect. - Antihypertensive agents: may diminish blood pressure control. - Oral hypoglycemics: possible alteration of glucose control.